These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 16307686
1. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. Leiros GJ, Galliano SR, Sember ME, Kahn T, Schwarz E, Eiguchi K. BMC Urol; 2005 Nov 24; 5():15. PubMed ID: 16307686 [Abstract] [Full Text] [Related]
2. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer. Aydin M, Bozkurt A, Cikman A, Gulhan B, Karabakan M, Gokce A, Alper M, Kara M. Int Braz J Urol; 2017 Nov 24; 43(1):36-46. PubMed ID: 28124524 [Abstract] [Full Text] [Related]
4. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T. Cancer Res; 1992 Oct 01; 52(19):5323-8. PubMed ID: 1327506 [Abstract] [Full Text] [Related]
5. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J. Prostate; 1996 May 01; 28(5):318-24. PubMed ID: 8610059 [Abstract] [Full Text] [Related]
6. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Katiyar S, Thelma BK, Murthy NS, Hedau S, Jain N, Gopalkrishna V, Husain SA, Das BC. Mol Cell Biochem; 2003 Oct 01; 252(1-2):117-24. PubMed ID: 14577584 [Abstract] [Full Text] [Related]
7. Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, Sarkar F, Schork A, Grossman HB, Shaw MW. Prostate; 1996 Feb 01; 28(2):117-23. PubMed ID: 8604392 [Abstract] [Full Text] [Related]
8. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Astori G, Merluzzi S, Arzese A, Brosolo P, de Pretis G, Maieron R, Pipan C, Botta GA. Digestion; 2001 Feb 01; 64(1):9-14. PubMed ID: 11549832 [Abstract] [Full Text] [Related]
9. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Summersgill KF, Smith EM, Kirchner HL, Haugen TH, Turek LP. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Sep 01; 90(3):334-9. PubMed ID: 10982955 [Abstract] [Full Text] [Related]
10. ras, p53 and HPV status in benign and malignant prostate tumors. Moyret-Lalle C, Marçais C, Jacquemier J, Moles JP, Daver A, Soret JY, Jeanteur P, Ozturk M, Theillet C. Int J Cancer; 1995 Apr 21; 64(2):124-9. PubMed ID: 7542226 [Abstract] [Full Text] [Related]
11. A multifaceted study of human papillomavirus and prostate carcinoma. Strickler HD, Burk R, Shah K, Viscidi R, Jackson A, Pizza G, Bertoni F, Schiller JT, Manns A, Metcalf R, Qu W, Goedert JJ. Cancer; 1998 Mar 15; 82(6):1118-25. PubMed ID: 9506358 [Abstract] [Full Text] [Related]
12. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N, Shanmugam G. Gynecol Oncol; 1998 Jun 15; 69(3):205-9. PubMed ID: 9648588 [Abstract] [Full Text] [Related]
13. Mutations of p53 and human papillomavirus infection in cervical carcinoma. Paquette RL, Lee YY, Wilczynski SP, Karmakar A, Kizaki M, Miller CW, Koeffler HP. Cancer; 1993 Aug 15; 72(4):1272-80. PubMed ID: 8393371 [Abstract] [Full Text] [Related]
14. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y, Nakamura Y. Cancer Res; 1998 Oct 15; 58(20):4585-6. PubMed ID: 9788606 [Abstract] [Full Text] [Related]
15. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations. Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N, Kawana K, Kozuka T, Nakagawa K, Aoki M, Taketani Y. Br J Cancer; 1999 Mar 15; 79(7-8):1139-44. PubMed ID: 10098748 [Abstract] [Full Text] [Related]
16. Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Noda T, Sasagawa T, Dong Y, Fuse H, Namiki M, Inoue M. Urol Res; 1998 Mar 15; 26(3):165-9. PubMed ID: 9694597 [Abstract] [Full Text] [Related]
18. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Iwasaka T, Oh-uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K, Fukuyama K, Hori K, Sugimori H. Gynecol Oncol; 1993 Jan 15; 48(1):104-9. PubMed ID: 8380785 [Abstract] [Full Text] [Related]
19. Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Tervahauta AI, Syrjänen SM, Väyrynen M, Saastamoinen J, Syrjänen KJ. Anticancer Res; 1993 Jan 15; 13(4):1107-11. PubMed ID: 8394670 [Abstract] [Full Text] [Related]
20. p53 polymorphism in human papillomavirus-associated esophageal cancer. Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, Tanaka S, Sugimachi K. Cancer Res; 2000 Jun 01; 60(11):2753-5. PubMed ID: 10850407 [Abstract] [Full Text] [Related] Page: [Next] [New Search]